News

The average stock on the S&P 500 yields just 1.3%. That's a modest return on your money, but that's only the average. There are many dividend stocks that pay you much more than that. While you don't

The S&P 500 (SNPINDEX: ^GSPC), the stock market's most widely followed index, has delivered slightly better than average returns over the past 12 months, rising by around 12%. However, the market's

An analyst's downbeat new take on Summit Therapeutics (NASDAQ: SMMT) pushed its stock downward on Hump Day. At the end of Wednesday, the shares had booked a loss of over 11% in price as investors

Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after

Shares of Summit Therapeutics (NASDAQ: SMMT) tanked more than 30% on Friday, May 30. Such dramatic price swings aren't unusual in the biotechnology industry; in this case, disappointing data from an

More than 100 million Americans use AT&T's (NYSE: T) products and services. So do nearly 2.5 million businesses. How many investors rely on A&T's stock to generate reliable dividend income? I don't

Shares of Summit Therapeutics (NASDAQ: SMMT) have plunged 31% as of 1:23 p.m. ET Friday, following the release of some trial data this morning.

Summit has been a tremendous winner over the past

AT&T (NYSE: T) is making waves again, climbing toward its 52-week high and locking in billion-dollar fiber deals. With rising cash flow, solid dividends, and 5G ambitions, is this legacy telecom

The 2020s did not start well for AT&T (NYSE: T) stock.

In the 2010s, the company veered from the wireless-focused business models of its competitors and invested heavily in non-core businesses such

The stock market isn't having a great year, with the S&P 500 down 0.4% at the time of this writing. Not all companies have been equally affected by tariff announcements and the possibility of a

Nearly every company that's even remotely related to the tech industry is betting that artificial intelligence (AI) will be a key driver of their business in the coming years. This is giving

Telecom giant AT&T (NYSE: T) doubled down on its fiber internet strategy on Wednesday with a $5.75 billion deal to acquire Lumen's Mass Markets fiber business. The acquisition will come with

Many investors love the "big mo." That's short for "big momentum." Stocks that are on a roll often keep the good times going.

Three Fool.com contributors think they've found high-flying biotech

Investing in growth stocks is a great way to grow your portfolio in the long run. But it can be difficult to predict which ones will take off in value and which one's won't. And that's why it might

AT&T's (NYSE: T) stock hit a 52-week high of $29.03 per share on April 3. That represented a gain of more than 60% over the previous year. Investors appear to have embraced AT&T for three reasons:

If you're looking to boost your passive income, Coca-Cola (NYSE: KO) and AT&T (NYSE: T) are solid dividend stock choices right now. These companies generate repeat revenue from consumers throughout

Venerable telecom titan AT&T (NYSE: T) is on a roll. Its shares soared to a 52-week high of $29.03 in April, the highest it's been since before the COVID-19 pandemic.This result is a dramatic

Summit Therapeutics (NASDAQ: SMMT) has more than just a potential blockbuster cancer drug in its portfolio. Ivonescimab could be one of the best drugs to ever hit the market. This has investors

It's hard to find a biotech company that has performed better than Summit Therapeutics (NASDAQ: SMMT) in the past year. The stock is up by a whopping 512%, and it's no secret why.

Summit, a

AT&T (NYSE: T) stock has been a strong performer, surging 64% over the last year. But Tigress Financial analyst Ivan Feinseth sees more upside following AT&T's first-quarter earnings report.

The

Billionaire Ken Griffin is a major supporter of President Donald Trump and donated $100 million last year to conservative groups. However, Griffin isn't a fan of all the president's policies.

He

AT&T (NYSE: T) is a leading telecom company in the country -- and as it has exited the streaming and media businesses and refocused on its core operations, it has been proving to be a solid

AT&T (NYSE: T) stock appears to be benefiting from its most promising outlook in years. Earlier in the decade, the stock suffered after the company slashed its dividend in 2022 following 35

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the place on Friday. Both U.S.-based Summit Therapeutics (NASDAQ: SMMT) and

There have been a lot of questions surrounding AT&T's (NYSE: T) dividend in recent years. The telecom giant already cut its payout by nearly 50% in 2022 to retain additional cash for debt reduction